Education
About Us
Working with TipRanks
Follow Us
Zeo ScientifiX (ZEOX)
OTHER OTC:ZEOX
ZEOX Stock Chart & Stats
$2.47
-$0.01(-0.37%)
At close: 4:00 PM EST
$2.47
-$0.01(-0.37%)
Day’s Range― - ―
52-Week Range$1.20 - $3.32
Previous CloseN/A
Volume825.00
Average Volume (3M)21.06K
Market Cap
$18.28M
Enterprise Value$14.38M
Total Cash (Recent Filing)$221.00K
Total Debt (Recent Filing)$110.00K
Price to Earnings (P/E)―
Beta1.06
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.78
Shares Outstanding7,614,941
10 Day Avg. Volume51,743
30 Day Avg. Volume21,062
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)-8.42
Price to Sales (P/S)2.31
P/FCF Ratio-16.18
Enterprise Value/Market Cap0.79
Enterprise Value/Revenue2.77
Enterprise Value/Gross Profit3.37
Enterprise Value/Ebitda-2.71
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Zeo ScientifiX News
ZEOX FAQ
What was Zeo ScientifiX’s price range in the past 12 months?
Zeo ScientifiX lowest stock price was $1.20 and its highest was $3.32 in the past 12 months.
What is Zeo ScientifiX’s market cap?
Zeo ScientifiX’s market cap is $18.28M.
When is Zeo ScientifiX’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Zeo ScientifiX’s earnings last quarter?
Currently, no data Available
Is Zeo ScientifiX overvalued?
According to Wall Street analysts Zeo ScientifiX’s price is currently Overvalued.
Does Zeo ScientifiX pay dividends?
Zeo ScientifiX does not currently pay dividends.
What is Zeo ScientifiX’s EPS estimate?
Zeo ScientifiX’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zeo ScientifiX have?
Zeo ScientifiX has 7,614,941 shares outstanding.
What happened to Zeo ScientifiX’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Zeo ScientifiX?
Currently, no hedge funds are holding shares in ZEOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zeo ScientifiX
Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. The company's lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, and knee osteoarthritis. It also provides Patient Pure X, an autologous blood-derived biologic technology, that helps the body's natural ability to decrease cellular inflammation and promote tissue healing. In addition, the company develops and distributes products that incorporate its proprietary ingredients for products to be used in topical aesthetic applications; ZEO GROW X, a professional-grade formula that delivers a concentrated dose of topical exosomes that help support follicular function; ZEO GROW BOOST; and EXO FOLLICLE FUEL. The company was formerly known as Organicell Regenerative Medicine, Inc. and changed its name to Zeo ScientifiX, Inc. in February 2024. Zeo ScientifiX, Inc. was incorporated in 2011 and is headquartered in Davie, Florida.
Technical Analysis
Imunon
―
XTL Biopharmaceuticals Sponsored ADR
―
Marker Therapeutics
―
Dogwood Therapeutics
―
AEON Biopharma
―